Evidence map›Paper›PMID 24486609›Full record

ArticleJournal of molecular biology2014

Structure and function of steroid receptor RNA activator protein, the proposed partner of SRA noncoding RNA.

David B McKay, Linghe Xi, Kristen K B Barthel, Thomas R Cech

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Getting to the bottom of lncRNA mechanism: structure-function relationships.Mammalian genome : official journal of the International Mammalian Genome Society · 2022
    Review
  3. Nuclear Receptors in Ovarian Function.Advances in experimental medicine and biology · 2022
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Idiopathic Hypogonadotropic Hypogonadism Caused by Inactivating Mutations in SRA1.Journal of clinical research in pediatric endocrinology · 2016
    Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

David B McKay *BioFrontiers Institute, University of Colorado, Boulder, CO 80309, USA.
Linghe Xi *BioFrontiers Institute, University of Colorado, Boulder, CO 80309, USA.
Kristen K B BarthelBioFrontiers Institute, University of Colorado, Boulder, CO 80309, USA.
Thomas R CechBioFrontiers Institute, University of Colorado, Boulder, CO 80309, USA.
University of Colorado Boulder · USHoward Hughes Medical Institute · US

Funding

TRAINING IN SIGNAL TRANSDUCTION &CELL CYCLE REGULATIONT32GM008759 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI AHN, NATALIE G. · 2000 to 2020
$5.9M
Predoctoral Training Program in Signaling and Cellular Regulation INCLUDE Down Syndrome SupplementT32GM142607 · NIGMS · UNIVERSITY OF COLORADO · PI Sabrina Leigh Spencer, Tin Tin Su · 2021 to 2026
$3.6M
American Heart Association-American Stroke Association 13POST14410014Howard Hughes Medical InstituteNIGMS NIH HHS T32 GM008759NIGMS NIH HHS T32 GM08759NIGMS NIH HHS T32 GM142607
6 · The paper itself

Abstract

In a widely accepted model, the steroid receptor RNA activator protein (SRA protein; SRAP) modulates the transcriptional regulatory activity of SRA RNA by binding a specific stem-loop of SRA. We first confirmed that SRAP is present in the nucleus as well as the cytoplasm of MCF-7 breast cancer cells, where it is expressed at the level of about 10(5) molecules per cell. However, our SRAP-RNA binding experiments, both in vitro with recombinant protein and in cultured cells with plasmid-expressed protein and RNA, did not reveal a specific interaction between SRAP and SRA. We determined the crystal structure of the carboxy-terminal domain of human SRAP and found that it does not have the postulated RRM (RNA recognition motif). The structure is a five-helix bundle that is distinct from known RNA-binding motifs and instead is similar to the carboxy-terminal domain of the yeast spliceosome protein PRP18, which stabilizes specific protein-protein interactions within a multisubunit mRNA splicing complex. SRA binding experiments with this domain gave negative results. Transcriptional regulation by SRA/SRAP was examined with siRNA knockdown. Effects on both specific estrogen-responsive genes and genes identified by RNA-seq as candidates for regulation were examined in MCF-7 cells. Only a small effect (~20% change) on one gene resulting from depletion of SRA/SRAP could be confirmed. We conclude that the current model for SRAP function must be reevaluated; we suggest that SRAP may function in a different context to stabilize specific intermolecular interactions in the nucleus.

Indexed as

Binding SitesCarrier ProteinsCell NucleusCrystallography, X-RayCytoplasmEstradiolGene Knockdown TechniquesHEK293 CellsHumansMCF-7 CellsModels, MolecularProtein BindingProtein Interaction Domains and MotifsRecombinant ProteinsRibonucleoprotein, U5 Small NuclearRNA, UntranslatedCarrier ProteinsEstradiolPRP18 protein, S cerevisiaeRecombinant ProteinsRibonucleoprotein, U5 Small NuclearRNA, UntranslatedSaccharomyces cerevisiae Proteinssteroid receptor RNA activator, humanestrogennuclear receptorRNA-binding proteinsteroid receptor activatortranscription factor

Identifiers

PMID24486609
PMCPMC4043375
OpenAlexW2061522883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.